Company performance
Add to research
Current Price
as of Jun 13, 2025$0.70
P/E Ratio
N/A
Market Cap
$88.43M
Description
Add to research
Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Metrics
Add to research
Overview
- HQSeattle, WA
- SectorHealth Technology
- IndustryBiotechnology
- TickerNAUT
- Price$0.701-1.78%
Trading Information
- Market cap$88.43M
- Float46.44%
- Average Daily Volume (1m)167,986
- Average Daily Volume (3m)186,099
- EPS-$0.55
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$16.61M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$17.22M
- EV-$0.86M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.45
- Debt/Equity15.09
Documents
Add to research
SEC Filings
Earnings Calls
Factset